B G Angeja
Affiliation: University of California
- Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2B G Angeja
Genentech Inc, South San Francisco, California, USA
Am J Cardiol 87:627-30, A9. 2001..However, the relative benefit was less evident in older patients and women, and some older subgroups did not benefit from treatment...
- Predictors of door-to-balloon delay in primary angioplastyBrad G Angeja
Cardiovascular Division, Department of Medicine, The University of California, San Francisco, San Francisco, California 94143, USA
Am J Cardiol 89:1156-61. 2002..These findings may help design treatment algorithms to minimize delay, thus improving the survival benefit of pPTCA. These results may also help design trials of combination reperfusion strategies...
- Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapyBrad G Angeja
Cardiovascular Division, Department of Medicine, University of California, San Francisco, Calif 94143, USA
Am Heart J 144:649-56. 2002..We studied the angiographic and electrocardiographic responses to thrombolytic agents in patients with diabetes; in particular ST-segment resolution as a measure of microvascular flow...
- Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-TrialB G Angeja
Cardiovascular Division, University of California San Francisco, San Francisco, California 94143 0124, USA
Am J Cardiol 88:1240-5. 2001..33). Adjustment for small baseline differences in this randomized sample did not change the results. Thus, across the range of estimated weight categories corresponding to each TNK dose, TNK is as safe and effective as t-PA...
- Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal womenB G Angeja
Department of Medicine, University of California, San Francisco, California 94143, USA
J Am Coll Cardiol 38:1297-301. 2001..We examined the association of hormone therapy (HRT) with hemorrhagic and ischemic stroke among postmenopausal women with acute myocardial infarction (AMI)...
- Use of reperfusion therapies in elderly patients with acute myocardial infarctionB G Angeja
Department of Medicine, University of California, San Francisco, Moffitt Hospital, 94143 0124, USA
Drugs Aging 18:587-96. 2001..Finally, newer, more fibrin-specific thrombolytics may decrease the bleeding risk associated with thrombolytic therapy...
- Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal womenM G Shlipak
General Internal Medicine Section, Veterans Affairs Medical Center, Department of Medicine, University of California, San Francisco, USA
Circulation 104:2300-4. 2001..CONCLUSIONS: Postmenopausal HRT appears to be associated with reduced mortality after myocardial infarction. This finding could be caused by therapeutic effect of HRT, selection and adherence bias, or some combination of both...
- The smoker's paradox: insights from the angiographic substudies of the TIMI trialsBrad G Angeja
Cardiovascular Division, Department of Medicine, University of California, San Francisco, USA
J Thromb Thrombolysis 13:133-9. 2002..We determined the clinical risk profiles and coronary flow characteristics of patients in the TIMI trials according to smoking status, focusing on microvascular flow...
- TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imagingBrad G Angeja
Department of Medicine, The University of California, San Francisco, USA
Circulation 105:282-5. 2002..0001). The difference in infarct size by TMPG persisted when stratified by category of ST resolution...
- Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending arteryC Michael Gibson
Harvard Clinical Research Institute and Brigham and Women s Hospital, Boston, MA 02215, USA
J Thromb Thrombolysis 13:9-12. 2002..To determine whether APSTD is associated with abnormal blood flow in the uninvolved or non-culprit LAD, we assessed TIMI flow grades and corrected TIMI frame counts (CTFC) in both the culprit and non-culprit arteries of IMI patients...